OUR IN-HOUSE AUDIENCE
35+
Different Countries
50%
Of All Attendees Are In-House Counsels
15+
Dedicated Net-Working Hours
50%
Representation of Generics & Innovators
Address Your Objectives
Challenge
Determine and benchmark the latest Life Sciences Patent Litigation with industry colleagues to ensure your patent portfolio is at the forefront with ever-changing regulation and laws.
Benefits from attending the event
Gain practical insights from leading judicial, industry and legal experts to disseminate the latest case laws, legal opinions and decisions to stay ahead in an ever-competitive market.
Sneak Peek of Session Highlights
1. Seek out industry inhouse perspectives on the important takeaways from most recent UPC life sciences cases including: Amgen vs Sanofi/Regeron | 10x Genomic vs Nanostring | Sanofi vs Generics
2. Novartis, Glenmark Pharmaceuticals and Euroimmun illustrate the importance and changes to patent litigation strategies in PI across UPC, National Courts, USA and further abroad
3. Litigate, Oppose, Licence or Settle? See what Adalvo, Valneva, Novo Nordisk and Brucker would think in different situations
4. Opt in or Opt out? For Medtech companies at the UPC? Join Biotronik and Siemens Healthineers on their reasoning and thinking behind important decisions
